Biogen (BIIB) EV to EBITDA (2009 - 2026)
Biogen's EV to EBITDA came in at 24.18 for Q3 2026, up 288.8% from 6.22 a year earlier and up 46.3% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EV to EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Biogen reported EV to EBITDA of 17.11, up 415.3% year-over-year; for FY2025, it came in at 9.42, up 22.0% from FY2024.
- Going back by year, EV to EBITDA was 7.72 in FY2024 (-62.0%), 20.34 in FY2023 (+139.1%), 8.51 in FY2022 (-10.2%) and 9.47 in FY2021 (+36.7%).
- The Q3 2026 figure represents the highest quarterly EV to EBITDA in data going back to Q2 2009.
- Year-over-year, EV to EBITDA has increased for four consecutive quarters, with growth averaging 36.1% over the last eight quarters.
- The fastest year-over-year change in EV to EBITDA over five years came in Q3 2026 (growth of 288.8%), and the weakest in Q2 2022 (a decline of 64.7%).
- Business Quant data shows BIIB's EV to EBITDA at 16.52 (Q2 2026), 9.40 (Q1 2026) and 9.42 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 24.18 |
| Jun 30, 2026 | 16.52 |
| Mar 31, 2026 | 9.40 |
| Dec 31, 2025 | 9.42 |
| Sep 30, 2025 | 6.22 |
| Jun 30, 2025 | 6.16 |
| Mar 31, 2025 | 7.09 |
| Dec 31, 2024 | 7.72 |
| Sep 30, 2024 | 10.47 |
| Jun 30, 2024 | 16.90 |
| Mar 31, 2024 | 16.36 |
| Dec 31, 2023 | 20.34 |
| Sep 30, 2023 | 16.77 |
| Jun 30, 2023 | 9.79 |
| Mar 31, 2023 | 8.44 |
| Dec 31, 2022 | 8.00 |
| Sep 30, 2022 | 7.67 |
| Jun 30, 2022 | 6.51 |
| Mar 31, 2022 | 9.01 |
| Dec 31, 2021 | 9.47 |
API Access
Biogen EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();